Approval · Notice of Compliance 37095 · 2026
BILDYOS: Notice of Compliance 37095
Issued March 9, 2026
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 37095
- Date
- March 9, 2026
- Company
- Shanghai Henlius Biotech, Inc.Shanghai, China
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Canadian reference product
- PROLIA